Media headlines about Bruker (NASDAQ:BRKR) have trended somewhat positive this week, Accern reports. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Bruker earned a news impact score of 0.19 on Accern’s scale. Accern also gave news stories about the medical research company an impact score of 46.272700141968 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Several analysts have recently weighed in on the stock. BidaskClub lowered shares of Bruker from a “buy” rating to a “hold” rating in a report on Saturday, February 10th. Morgan Stanley dropped their price objective on shares of Bruker from $35.00 to $32.00 and set an “equal weight” rating for the company in a report on Friday, February 9th. Leerink Swann raised their price objective on shares of Bruker from $32.00 to $34.00 and gave the stock a “market perform” rating in a report on Friday, February 9th. Zacks Investment Research lowered shares of Bruker from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Finally, BTIG Research assumed coverage on shares of Bruker in a report on Friday, January 5th. They set a “buy” rating and a $42.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $32.62.
Shares of Bruker stock traded down $0.07 during trading on Monday, hitting $29.96. 387,176 shares of the company were exchanged, compared to its average volume of 536,656. The company has a current ratio of 2.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $4,684.88, a price-to-earnings ratio of 61.14, a P/E/G ratio of 1.99 and a beta of 1.16. Bruker has a fifty-two week low of $21.83 and a fifty-two week high of $36.53.
Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, February 8th. The medical research company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.02. The business had revenue of $530.50 million during the quarter, compared to analyst estimates of $506.74 million. Bruker had a net margin of 4.45% and a return on equity of 26.58%. Bruker’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.46 earnings per share. equities analysts anticipate that Bruker will post 1.37 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Tuesday, March 6th will be issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date is Monday, March 5th. Bruker’s dividend payout ratio is currently 32.65%.
COPYRIGHT VIOLATION NOTICE: “Bruker (BRKR) Receiving Somewhat Favorable News Coverage, Study Finds” was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://ledgergazette.com/2018/03/20/bruker-brkr-receiving-somewhat-favorable-news-coverage-study-finds.html.
Bruker Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.